Chemical Compound

N-(Trifluoroacetyl)daunorubicin

CAS Registry Number 26388-52-3
N-(Trifluoroacetyl)daunorubicin chemical structure
Primary Record

N-(Trifluoroacetyl)daunorubicin

In stock
1,630 g
Purity
99.0 %
CAS
26388-52-3

Compound Identifiers & Properties

CAS
26388-52-3
PubChem CID
161522
SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(F)(F)F)O
Canonical SMILES
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1

Names & Synonyms

  • N-(Trifluoroacetyl)daunorubicin
  • Trifluoroacetyldaunomycin
  • N-(Trifluoroacetyl)daunomycin
  • RefChem:191586
  • 26388-52-3
  • AC1L4PL6
  • N-trifluoroacetyldaunorubicin
  • VOASREXNXKOKBP-HWJSKKJZSA-N
  • N-trifluoroacetyl daunorubicin
  • C29H28F3NO11
  • CHEMBL383543
  • Idarubicin HCL Intermediates 1
  • DTXSID50949278
  • N-?(Trifluoroacetyl)?daunorubicin
  • KST-1A7932
  • KST-1A7933
  • 8179AH
  • AR-1A1611
  • AR-1A1612
  • CID161522
  • ZINC28570684
  • C29-H28-F3-N-O11
  • J1.353.030K
  • N-[(2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2,2,2-trifluoroacetamide
  • (1s,3s)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-|A-l-lyxo-hexopyranoside
  • 7321-13-3
  • 73212-00-7
  • (1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2,2,2-trifluoro-1-hydroxyethylidene)amino]-alpha-L-lyxo-hexopyranoside
  • (8S)-1-Methoxy-6,8alpha,11-trihydroxy-8-acetyl-10alpha-[[3-[(trifluoroacetyl)amino]-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-5,12-naphthacenedione
  • (8S,10S)-8-Acetyl-10-[[3-(trifluoroacetylamino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
  • (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-|A-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
  • 3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2,2,2-trifluoro-1-hydroxyethylidene)amino]hexopyranoside
  • 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-
  • N-(Trifluoroacetyl)daunomycin; (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione;
  • N-[(2S,3S,4S,6R)-6-{[(1S,3S)-3-ACETYL-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1,2,3,4,6,11-HEXAHYDROTETRACEN-1-YL]OXY}-3-HYDROXY-2-METHYLOXAN-4-YL]-2,2,2-TRIFLUOROACETAMIDE